Paushak Ltd
Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907. [1][2]
- Market Cap ₹ 1,789 Cr.
- Current Price ₹ 5,803
- High / Low ₹ 6,915 / 4,464
- Stock P/E 32.9
- Book Value ₹ 1,324
- Dividend Yield 0.31 %
- ROCE 18.7 %
- ROE 14.3 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 8.13% over past five years.
- Dividend payout has been low at 10.4% of profits over last 3 years
- Working capital days have increased from 169 days to 333 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | 54 | 69 | 78 | 72 | 105 | 140 | 138 | 141 | 150 | 212 | 206 | |
39 | 43 | 52 | 61 | 60 | 75 | 99 | 95 | 91 | 96 | 137 | 142 | |
Operating Profit | 12 | 11 | 17 | 17 | 12 | 29 | 40 | 43 | 50 | 54 | 75 | 64 |
OPM % | 23% | 20% | 25% | 22% | 17% | 28% | 29% | 31% | 36% | 36% | 35% | 31% |
1 | 4 | 3 | 3 | 5 | 3 | 13 | 7 | 6 | 5 | 11 | 20 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 5 | 9 | 13 | 14 |
Profit before tax | 11 | 13 | 18 | 17 | 14 | 29 | 49 | 45 | 52 | 50 | 72 | 71 |
Tax % | 27% | 30% | 28% | 25% | 22% | 26% | 20% | 23% | 28% | 25% | 25% | 23% |
8 | 9 | 13 | 12 | 11 | 21 | 39 | 35 | 37 | 38 | 54 | 54 | |
EPS in Rs | 24.29 | 27.50 | 40.50 | 38.73 | 34.11 | 66.95 | 126.41 | 113.27 | 121.02 | 122.03 | 175.24 | 176.34 |
Dividend Payout % | 12% | 11% | 7% | 8% | 9% | 4% | 4% | 5% | 5% | 10% | 10% | 11% |
Compounded Sales Growth | |
---|---|
10 Years: | 14% |
5 Years: | 8% |
3 Years: | 14% |
TTM: | -3% |
Compounded Profit Growth | |
---|---|
10 Years: | 20% |
5 Years: | 12% |
3 Years: | 15% |
TTM: | 8% |
Stock Price CAGR | |
---|---|
10 Years: | 40% |
5 Years: | 18% |
3 Years: | -9% |
1 Year: | -15% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 14% |
3 Years: | 14% |
Last Year: | 14% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Reserves | 35 | 42 | 54 | 65 | 80 | 110 | 174 | 224 | 269 | 302 | 351 | 405 |
1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
8 | 8 | 11 | 13 | 11 | 31 | 36 | 43 | 57 | 61 | 61 | 73 | |
Total Liabilities | 47 | 54 | 69 | 82 | 94 | 144 | 214 | 270 | 329 | 367 | 415 | 481 |
10 | 9 | 18 | 20 | 35 | 37 | 38 | 41 | 51 | 147 | 149 | 152 | |
CWIP | 0 | 4 | 1 | 12 | 0 | 1 | 6 | 16 | 68 | 8 | 7 | 29 |
Investments | 14 | 18 | 19 | 18 | 33 | 53 | 116 | 163 | 154 | 151 | 182 | 223 |
23 | 23 | 30 | 31 | 26 | 54 | 54 | 50 | 56 | 61 | 78 | 77 | |
Total Assets | 47 | 54 | 69 | 82 | 94 | 144 | 214 | 270 | 329 | 367 | 415 | 481 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 9 | 9 | 14 | 12 | 10 | 24 | 45 | 30 | 44 | 43 | 56 | |
0 | -7 | -8 | -13 | -11 | -10 | -0 | -43 | -29 | -42 | -38 | -50 | |
-3 | -2 | -1 | -1 | -2 | -1 | -23 | -2 | -2 | -2 | -4 | -5 | |
Net Cash Flow | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -1 | -0 | 0 | 0 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 102 | 96 | 114 | 97 | 83 | 135 | 85 | 69 | 85 | 97 | 90 | 90 |
Inventory Days | 133 | 117 | 96 | 117 | 125 | 118 | 122 | 131 | 148 | 233 | 180 | 177 |
Days Payable | 79 | 71 | 94 | 104 | 70 | 170 | 73 | 110 | 118 | 227 | 122 | 130 |
Cash Conversion Cycle | 155 | 142 | 116 | 110 | 138 | 83 | 133 | 89 | 115 | 103 | 149 | 137 |
Working Capital Days | 115 | 108 | 110 | 95 | 92 | 109 | 100 | 75 | 60 | 81 | 93 | 333 |
ROCE % | 30% | 30% | 32% | 25% | 12% | 29% | 27% | 21% | 20% | 17% | 21% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
3m - With reference to the captioned subject, we enclose herewith a copy of the notice published in English language and vernacular language (Gujarati) newspaper on 4th …
- Record Date For Payment Of Dividend On Equity Shares For The Financial Year Ended 31St March, 2024. 21h
- Business Responsibility and Sustainability Reporting (BRSR) 22h
- Reg. 34 (1) Annual Report. 22h
- Notice Of 51St Annual General Meeting Of The Company 22h
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Products Offered
Paushak is part of the Alembic group of companies situated in Gujarat, India and is the largest specialty chemical company in India based on Phosgene Chemistry. Its products include Chloroformates, Isocyanates, Chlorides, Carbonates/Carbamate and Other Chemicals. These chemicals are used in diverse fields such as pesticides, pharmaceuticals dyes plastics and perfumeries. [1] [2]